Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.610
+0.110 (7.33%)
At close: Oct 29, 2024, 4:00 PM
1.629
+0.019 (1.19%)
After-hours: Oct 29, 2024, 6:53 PM EDT
Regulus Therapeutics Market Cap
Regulus Therapeutics has a market cap or net worth of $105.40 million as of October 29, 2024. Its market cap has increased by 328.46% in one year.
Market Cap
105.40M
Enterprise Value
12.37M
1-Year Change
328.46%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since December 31, 2012, Regulus Therapeutics's market cap has decreased from $225.70M to $105.40M, a decrease of -53.30%. That is a compound annual growth rate of -6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 98.20M | 279.15% |
| Dec 29, 2023 | 25.90M | 12.12% |
| Dec 30, 2022 | 23.10M | -15.69% |
| Dec 31, 2021 | 27.40M | -48.20% |
| Dec 31, 2020 | 52.90M | 184.41% |
| Dec 31, 2019 | 18.60M | 129.63% |
| Dec 31, 2018 | 8.10M | -92.51% |
| Dec 29, 2017 | 108.10M | -9.24% |
| Dec 30, 2016 | 119.10M | -73.90% |
| Dec 31, 2015 | 456.40M | -41.46% |
| Dec 31, 2014 | 779.60M | 152.54% |
| Dec 31, 2013 | 308.70M | 36.77% |
| Dec 31, 2012 | 225.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| So-Young International | 99.97M |
| FibroBiologics | 99.43M |
| FONAR | 99.36M |
| Genenta Science | 98.77M |
| MDxHealth | 98.36M |
| AlloVir | 97.49M |
| I-Mab | 96.91M |
| Milestone Pharmaceuticals | 95.96M |